SCHEMBL7712401

SCHEMBL7712401

Clc1ncc(Cc2ccccc2)c(N2CCOCC2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.50
MAPT P10636 2/20 0.48
GAA P10253 1/20 0.46
PKM P14618 1/20 0.46
HTR2C P28335 1/20 0.46
HTR2B P41595 1/20 0.46
ALDH1A1 P00352 3/20 0.45
TSHR P16473 3/20 0.45
HSD17B10 Q99714 3/20 0.45
ALOX15 P16050 1/20 0.45
MAPK1 P28482 1/20 0.45
POLB P06746 1/20 0.44
AKT1 P31749 1/20 0.44
PIK3CA P42336 1/20 0.44
KDM4E B2RXH2 2/20 0.43
HRH3 Q9Y5N1 1/20 0.43
CYP11B2 P19099 1/20 0.43
DRD1 P21728 1/20 0.42
DRD4 P21917 1/20 0.42
DRD5 P21918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708590 0.88 MAPT (0.47) HPGDMAPTGAAPKMALDH1A1
SCHEMBL7708464 0.85 KDM4E (0.54) HPGDMAPTGAAHTR2CHTR2B
SCHEMBL7708466 0.84 SMN1; SMN2 (0.55) MAPT
SCHEMBL7714543 0.84 PIK3CA (0.55) HPGDGAAPKMHTR2CHTR2B
SCHEMBL7716622 0.82 MAPT (0.43) MAPTMAPK1PIK3CAHRH3
SCHEMBL7714116 0.77 DHFR (0.50) PKMAKT1PIK3CAKDM4ECYP11B2
SCHEMBL7711748 0.74 ALDH1A1 (0.54) HPGDGAAALDH1A1TSHRHSD17B10
SCHEMBL1935491 0.74 KDM4E (0.46) MAPTGAAALDH1A1TSHRALOX15
SCHEMBL7708477 0.73 MGMT (0.48) HPGDGAAPKMALDH1A1TSHR
SCHEMBL7711799 0.73 OGA (0.47) HPGDGAAPKMALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed